Incannex Healthcare Inc. has announced a significant capital reduction through the cancellation of up to 50.4% of its Series A Warrants. This move will eliminate a potential issuance of up to 175.2 million additional shares, thereby reducing potential future dilution for shareholders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incannex Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-045651), on May 20, 2025, and is solely responsible for the information contained therein.